Interações medicamentosas
Betibeglogene autotemcel + Dolutegravir
Gravidade: Grave
Betibeglogene autotemcel and Dolutegravir: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Dolutegravir exposure during apheresis could reduce product quality.
O que esta interação significa em palavras simples
Betibeglogene autotemcel and Dolutegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Por que acontece
Antiretroviral activity inhibits lentiviral vector integration in collected cells.
O que fazer
Discontinue dolutegravir at least one month before mobilization and until all apheresis cycles are completed. Coordinate an interim HIV plan with an infectious disease specialist.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Betibeglogene autotemcel e Dolutegravir, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Dolutegravir
Perguntas frequentes
Can I take Betibeglogene autotemcel with Dolutegravir?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Dolutegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Dolutegravir exposure during apheresis could reduce product quality.
How serious is the interaction between Betibeglogene autotemcel and Dolutegravir?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue dolutegravir at least one month before mobilization and until all apheresis cycles are completed. Coordinate an interim HIV plan with an infectious disease specialist.
What other medicines interact with Dolutegravir?
MediHelp also lists interactions of Dolutegravir with, for example, Dofetilide, Aluminum hydroxide, Atidarsagene autotemcel. The full list is on the Dolutegravir page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
